Neuroblastoma: open trials in China

26 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT04637503
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-10-30
NCT07318831
Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
Trial Treatment · Phase 2 · Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Registry updated 2026-10-01
NCT05701306
APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
Trial Treatment · Phase 1/2 · Ascentage Pharma Group Inc.
Sun Yat-sen University Cancer Center, Guangzhou · Tianjin Medical University Cancer Institute & Hospital, Tianjin · Tongji Hospital, Huazhong University of Science and Technology (HUST), Wuhan
Registry updated 2026-08-21
NCT07767630
Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
Trial Treatment · Early phase 1 · Sichuan University
West China Hospital, Chengdu
Registry updated 2026-08-21
NCT07584499
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Sun Yat-sen University
Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2026-05-13
NCT07516678
Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
Research · Sun Yat-sen University
Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2026-04-08
NCT07502287
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Trial Treatment · Phase 1/2 · Beijing Biotech
Peking University Shenzhen Hospital, Shenzhen
Registry updated 2026-03-30
NCT06818916
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
Trial Treatment · Beijing Children's Hospital
Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University, Beijing
Registry updated 2025-12-03
NCT07195500
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
Research · Nanjing First Hospital, Nanjing Medical University
Nanjing First Hospital, Nanjing
Registry updated 2025-09-26
NCT06852807
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
Research · First Affiliated Hospital of Zhejiang University
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Registry updated 2025-08-08
NCT07067346
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
Trial Treatment · Early phase 1 · Sichuan University
West China Hospital, Chengdu
Registry updated 2025-07-29
NCT07090538
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
Trial Treatment · Early phase 1 · Chinese PLA General Hospital
Department of Pediatrics, The First Medical Center, Chinese PLA General Hospital, Beijing · Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital, Beijing
Registry updated 2025-07-29
NCT07064746
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Research · Nanjing First Hospital, Nanjing Medical University
Nanjing First Hospital, Nanjing
Registry updated 2025-07-21
NCT06013618
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Trial Treatment · Phase 2 · Sun Yat-Sen University Cancer Center
Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2025-06-17
NCT06703944
Risk Model for Metastasis Detection of Neuroblastoma
Research · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
The Children's Hospital, Zhejiang University School of Medicine, Hangzhou · Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai · Shenzhen Children's Hospital, Shenzhen
Registry updated 2025-05-15
NCT06933394
Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
Trial Treatment · Phase 2 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen Memorial Hospital, Guangzhou
Registry updated 2025-04-18
NCT06873672
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Research · RenJi Hospital
Guizhou Medical University, Guiyang
Registry updated 2025-03-13
NCT06836505
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
Trial Treatment · Phase 1/2 · Sun Yat-Sen University Cancer Center
Dongguan Taixin Hospital, Dongguan · Sun Yat-sen University Cancer Center, Guangzhou · Shanghai YaKe Biotechnology Ltd., Shanghai
Registry updated 2025-02-26
NCT06631391
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
Trial Treatment · Phase 1 · Sun Yat-sen University
Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2025-02-20
NCT06751134
Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
Trial Treatment · Phase 1 · Nanjing Children's Hospital
Nanjing Children's Hospital, Nanjing · Nanjing, Nanjing
Registry updated 2025-02-07
NCT06684639
A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
Trial Treatment · Early phase 1 · The General Hospital of Western Theater Command
The General Hospital of Western Theater Command, Chengdu
Registry updated 2024-12-20
NCT06574698
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
Research · Guangzhou Women and Children's Medical Center
Guangzhou Women And Children's Medical Center, Guanzhou
Registry updated 2024-08-28
NCT05069220
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Trial Treatment · Early phase 1 · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2024-03-01
NCT06255210
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Trial Treatment · Phase 2 · Hongmeng Yu
Eye ENT Hospital of Fudan University, Shanghai
Registry updated 2024-02-13
NCT05562024
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Trial Treatment · Phase 1 · PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Shandong Cancer Hospital and Institute, Jinan · Tianjin Medical University Cancer Institute and Hospital, Tianjin
Registry updated 2023-02-27

All Neuroblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error